Key result
The new pediatric hypertension guideline increased hypertension prevalence from 8% to 13% (P=0.007) and improved sensitivity for detecting abnormal left ventricular mass from 20% to 31% (P<0.001).
Why the study?
Does the new pediatric hypertension clinical practice guideline improve the sensitivity of target organ damage detection compared to the previous guideline in high-risk youth?
Cross-Sectional (n=364)
Does the new pediatric hypertension clinical practice guideline improve the sensitivity of target organ damage detection compared to the previous guideline in high-risk youth?
Absolute Event Rate: 13% vs 8%
p-value: p=.007
The revised AAP pediatric hypertension guidelines increase the identified prevalence of hypertension and improve the sensitivity of detecting target organ damage in high-risk youth with obesity and type 2 diabetes.
May improve hypertension and LV mass detection in high-risk youth; leaves open prospective outcome validation.
BACKGROUND AND OBJECTIVES: New pediatric hypertension definitions were recently published in a clinical practice guideline (CPG). We evaluated the impact of the CPG, compared with the previous guideline ("Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents"), on the prevalence of hypertension and associations with target organ damage (TOD) in high-risk youth. METHODS: Participants (10–18 years old) undergoing an evaluation of the cardiovascular effects of obesity and type 2 diabetes mellitus in youth were studied. Blood pressure was categorized according to the 2 guidelines as normal, elevated, and hypertension (stages 1 and 2). Measures of TOD (carotid artery intima-media thickness, pulse wave velocity, left ventricular mass, and diastolic function) were obtained. Associations between blood pressure categories and TOD and the sensitivity of hypertension classification in identifying TOD were evaluated. RESULTS: Data were available for 364 participants (65% female sex; 15.1 ± 2.1 years of age). Hypertension was identified in 8% and 13% as defined in the Fourth Report and CPG, respectively (P = .007). The 2 guidelines revealed similar associations with TOD; however, the CPG demonstrated improved sensitivity of TOD detection in hypertensive participants. For example, the proportion of participants with an abnormal left ventricular mass categorized as hypertensive increased from 20% to 31% as defined in the Fourth Report and CPG, respectively (P < .001). CONCLUSIONS: Incorporation of the CPG increased the prevalence of pediatric hypertension in a population of high-risk youth and improved the sensitivity of TOD identification in hypertensive participants.
No takes yet. Share an insight, caveat, or question.
Khoury et al. (2018) conducted a cross-sectional in Obesity and type 2 diabetes mellitus (n=364). New pediatric hypertension clinical practice guideline (CPG) vs. Previous guideline (Fourth Report) was evaluated on Prevalence of hypertension (p=.007). The new pediatric hypertension guideline increased hypertension prevalence from 8% to 13% (P=0.007) and improved sensitivity for detecting abnormal left ventricular mass from 20% to 31% (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: